Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases
Conditions
- Clear Cell Renal Cell Cancer (ccRCC)
- Clear Cell Renal Carcinoma
- Clear Cell Renal Cell Carcinoma Metastatic
- Clear Cell Renal Cancer
- Bone Metastases of a Malignant Tumor
- Clear Cell Renal Cell Carcinoma
- Bone, Metastatic Cancer
- Metastatic Cancer
- Metastatic Renal Cell Carcinoma
- Metastases to Bone
Interventions
- DRUG: Zanzalintinib
- DRUG: Investigator Choice of Bone Strengthening Agents (BSA)
- RADIATION: Non-Investigational Radiation Therapy (RT)
- PROCEDURE: Bone Scan
- PROCEDURE: Computerized tomography (CT) Scan
Sponsor
Kelly Fitzgerald, MD
Collaborators